[go: up one dir, main page]

PT1173435E - Polimorfo de 5-¬4-¬2-(n-metil-n-(2-piridil)-amino)-etoxi|benzil|tiazolidino-2,4-diona sal de acido maleico - Google Patents

Polimorfo de 5-¬4-¬2-(n-metil-n-(2-piridil)-amino)-etoxi|benzil|tiazolidino-2,4-diona sal de acido maleico

Info

Publication number
PT1173435E
PT1173435E PT00920892T PT00920892T PT1173435E PT 1173435 E PT1173435 E PT 1173435E PT 00920892 T PT00920892 T PT 00920892T PT 00920892 T PT00920892 T PT 00920892T PT 1173435 E PT1173435 E PT 1173435E
Authority
PT
Portugal
Prior art keywords
diona
thiazolidine
pyridyl
benzyl
ethyl
Prior art date
Application number
PT00920892T
Other languages
English (en)
Inventor
Robert Gordon Giles
Paul David James Blackler
Christine Marie Browne
Timothy G Coakley
Gillian Morrissey
Original Assignee
Smithkline Beecham Cork Ltd
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1173435(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909473.2A external-priority patent/GB9909473D0/en
Priority claimed from GBGB9912196.4A external-priority patent/GB9912196D0/en
Application filed by Smithkline Beecham Cork Ltd, Smithkline Beecham Plc filed Critical Smithkline Beecham Cork Ltd
Publication of PT1173435E publication Critical patent/PT1173435E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT00920892T 1999-04-23 2000-04-19 Polimorfo de 5-¬4-¬2-(n-metil-n-(2-piridil)-amino)-etoxi|benzil|tiazolidino-2,4-diona sal de acido maleico PT1173435E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909473.2A GB9909473D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912196.4A GB9912196D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
PT1173435E true PT1173435E (pt) 2003-12-31

Family

ID=26315461

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00920892T PT1173435E (pt) 1999-04-23 2000-04-19 Polimorfo de 5-¬4-¬2-(n-metil-n-(2-piridil)-amino)-etoxi|benzil|tiazolidino-2,4-diona sal de acido maleico

Country Status (40)

Country Link
US (2) US6806280B1 (pt)
EP (2) EP1173435B1 (pt)
JP (1) JP2002543077A (pt)
KR (1) KR100744360B1 (pt)
CN (1) CN1167702C (pt)
AP (1) AP1598A (pt)
AR (2) AR023561A1 (pt)
AT (1) ATE246191T1 (pt)
AU (1) AU765005B2 (pt)
BG (1) BG65485B1 (pt)
BR (1) BR0009932A (pt)
CA (1) CA2370280A1 (pt)
CO (1) CO5170421A1 (pt)
CZ (1) CZ20013800A3 (pt)
DE (1) DE60004196T2 (pt)
DK (1) DK1173435T3 (pt)
DZ (1) DZ3156A1 (pt)
EA (1) EA004541B1 (pt)
ES (1) ES2203453T3 (pt)
HK (1) HK1045153B (pt)
HR (1) HRP20010772B1 (pt)
HU (1) HUP0200931A3 (pt)
IL (1) IL146111A0 (pt)
MA (1) MA25356A1 (pt)
MX (1) MXPA01010821A (pt)
MY (1) MY131973A (pt)
NO (1) NO320574B1 (pt)
NZ (1) NZ515168A (pt)
OA (1) OA11872A (pt)
PE (1) PE20010044A1 (pt)
PL (1) PL351684A1 (pt)
PT (1) PT1173435E (pt)
SK (1) SK286427B6 (pt)
TR (1) TR200103062T2 (pt)
TW (1) TWI283677B (pt)
UA (1) UA67844C2 (pt)
UY (1) UY26121A1 (pt)
WO (1) WO2000064896A1 (pt)
YU (1) YU75301A (pt)
ZA (1) ZA200108719B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
ES2204557T3 (es) 1999-04-23 2004-05-01 Smithkline Beecham Plc Derivado de tiazolidindiona y su uso como antidiabetico.
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
ATE246191T1 (de) * 1999-04-23 2003-08-15 Smithkline Beecham Plc Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
IL155036A0 (en) * 2000-09-26 2003-10-31 Reddy Research Foundation Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
US7241895B2 (en) 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
CZ305162B6 (cs) * 2002-04-19 2015-05-27 Faes Farma, S.A. Polymorf 1 bilastinu, způsob jeho přípravy a lékařské aplikace a farmaceutický přípravek s jeho obsahem
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (en) * 2004-01-28 2006-10-11 Usv Limited A process for the preparation of 5- 4- 2- n-methyl -n-(2-pyridyl) amino ethoxy phenyl methyl thiaz olidine-2, 4-dione maleate
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体
MX2019007073A (es) 2016-12-16 2019-10-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US6462337B1 (en) * 2000-04-20 2002-10-08 Agilent Technologies, Inc. Mass spectrometer electrospray ionization
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US6632947B2 (en) * 1997-02-18 2003-10-14 Smithkline Beecham Plc Process for the preparation of substituted thiazolidinedione
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US7091359B2 (en) * 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6613785B2 (en) * 1998-07-21 2003-09-02 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
DZ3164A1 (fr) 1999-04-23 2000-11-02 Smithkline Beecham Plc Nouvel agent pharmaceutique.
ATE246191T1 (de) * 1999-04-23 2003-08-15 Smithkline Beecham Plc Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
ES2204557T3 (es) * 1999-04-23 2004-05-01 Smithkline Beecham Plc Derivado de tiazolidindiona y su uso como antidiabetico.
CN1277965A (zh) 2000-06-14 2000-12-27 中国医药研究开发中心 盐酸罗格列酮及其应用
IL155036A0 (en) 2000-09-26 2003-10-31 Reddy Research Foundation Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
HUP0200931A3 (en) 2004-03-29
CA2370280A1 (en) 2000-11-02
OA11872A (en) 2006-03-27
TWI283677B (en) 2007-07-11
EP1173435A1 (en) 2002-01-23
HRP20010772B1 (en) 2007-05-31
BG106121A (en) 2002-05-31
MA25356A1 (fr) 2001-12-31
SK286427B6 (sk) 2008-09-05
MY131973A (en) 2007-09-28
HK1045153A1 (en) 2002-11-15
KR100744360B1 (ko) 2007-07-30
CN1167702C (zh) 2004-09-22
AU765005B2 (en) 2003-09-04
DZ3156A1 (fr) 2000-11-02
AU4130800A (en) 2000-11-10
NO320574B1 (no) 2005-12-27
US20050080114A1 (en) 2005-04-14
WO2000064896A9 (en) 2001-10-25
AR023561A1 (es) 2002-09-04
AR023565A1 (es) 2002-09-04
SK14922001A3 (sk) 2002-02-05
EA004541B1 (ru) 2004-06-24
MXPA01010821A (es) 2003-09-04
BG65485B1 (bg) 2008-09-30
IL146111A0 (en) 2002-07-25
NZ515168A (en) 2004-02-27
HUP0200931A2 (en) 2002-08-28
EP1304330A3 (en) 2003-11-19
ZA200108719B (en) 2002-06-21
HK1045153B (zh) 2004-07-09
CO5170421A1 (es) 2002-06-27
ATE246191T1 (de) 2003-08-15
DE60004196T2 (de) 2004-04-15
JP2002543077A (ja) 2002-12-17
CZ20013800A3 (cs) 2002-04-17
EP1173435B1 (en) 2003-07-30
DK1173435T3 (da) 2003-11-24
WO2000064896A1 (en) 2000-11-02
HRP20010772A2 (en) 2002-10-31
TR200103062T2 (tr) 2002-05-21
BR0009932A (pt) 2002-04-09
EA200101121A1 (ru) 2002-04-25
CN1356999A (zh) 2002-07-03
NO20015147D0 (no) 2001-10-22
US6806280B1 (en) 2004-10-19
NO20015147L (no) 2001-12-17
PL351684A1 (en) 2003-06-02
AP1598A (en) 2006-04-26
ES2203453T3 (es) 2004-04-16
YU75301A (sh) 2004-07-15
KR20010110797A (ko) 2001-12-13
UA67844C2 (uk) 2004-07-15
DE60004196D1 (de) 2003-09-04
EP1304330A2 (en) 2003-04-23
PE20010044A1 (es) 2001-03-10
AP2001002330A0 (en) 2000-12-31
UY26121A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
PT1173435E (pt) Polimorfo de 5-¬4-¬2-(n-metil-n-(2-piridil)-amino)-etoxi|benzil|tiazolidino-2,4-diona sal de acido maleico
NO20021988D0 (no) Overvåkningssystem for avleiringer
IT1312018B1 (it) Procedimento migliorato per la produzione di sali non igroscopicidella l(-)-carnitina.
IT1319694B1 (it) Sali di iodonio come donatori di acidi latenti.
ATE228995T1 (de) Aminomethylcarbonsäurederivate
PT1240172E (pt) Novos acidos aminopropilfosfinicos
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
DE60007050D1 (de) IMC-Verfahren
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
EE200100708A (et) Asendatud fenoksüäädikhapped
ID27270A (id) Aparatus pemroses informasi program siaran
ATE309220T1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
DE60019993D1 (de) Wässrige Lysinlösungen
ITUD990152A0 (it) Cingolo per gruppo di traino di macchine trafilatrici
PL341601A1 (en) Monoargininyl salt of (e)-3-[1-n-butyl-5-(2-(2-carboxyphenyl)methoxy-4-chlorophenyl)-1h-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzzofuran-6-yl)methyl]-2-propenic acid
ATA170799A (de) Schmiedemaschine
MA25412A1 (fr) Procede pour la preparation d'acides 2-(n-phenylamino) benzoiques.
DE10081188D2 (de) Melken
ITTO20000965A0 (it) Procedimento per produrre l'acido monocarbossilico + )-trans-crisantemico.
FR2799002B1 (fr) Procede d'imagerie laser active
AR028237A1 (es) Soluciones de acido acetilsalicilico
NO20021349D0 (no) Transformerte melkesyrebakterier
AU2001282565A1 (en) Process for preparing optically active carboxylic acid derivative
IL152681A0 (en) Process for the preparation of 4-(4-pyridinyl)benzoic acid, or a salt thereof